![]() |
|
|
Vol. 293, Issue 2, 662-669, May 2000
Department of Molecular Pharmacology and Neuroscience, Nagasaki
University School of Pharmaceutical Sciences, Nagasaki, Japan
We studied the acute tolerance liability of peripheral
opioid analgesia in mice. The analgesia was assessed by the inhibition of bradykinin (BK)-induced nociceptive action by using a newly developed flexor reflex paradigm. Morphine [intraplantarly
(i.pl.)] given ipsilaterally to BK showed a dose-dependent
reduction of the BK (2 pmol) responses, whereas the administration of
10 nmol of morphine into the contralateral side failed to show any
significant analgesic effects. Furthermore, DAMGO
([D-Ala2,MePhe4,Gly-ol5]-enkephalin),
a µ-opioid receptor (MOR) agonist, and U-69593, a
-opioid receptor
(KOR) agonist, but not DSLET
([D-Ser2]Leu-enkephalin-Thr6), a
-opioid receptor agonist, showed similar analgesia on the BK
responses. The morphine- or U-69593
[(5
,7
,8
)-(+)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4,5]dec-8yl] benzeneacetamide]-induced analgesia was markedly attenuated by the intrathecal injection of each antisense oligodeoxynucleotide for
the MOR or KOR, respectively, suggesting that these peripheral analgesia are mediated through MORs and KORs located on nociceptor endings, respectively. As BK response was completely recovered to the control level 4 h after morphine (3 nmol i.pl.) or U-69593 (10 nmol i.pl.) administration, these compounds were challenged again
to see the inhibition of BK responses. Although morphine analgesia by
the second challenge was markedly attenuated, U-69593 analgesia was
not. The attenuated morphine analgesia was completely reversed by the
pretreatment of calphostin C, Go6976, or HBDDE, a protein kinase
C inhibitor, but not by KT-5720, a protein kinase A inhibitor. These
results suggest that selective acute tolerance of peripheral morphine
analgesia, but not U-69593 analgesia, through MORs and KORs located on
polymodal nociceptors, respectively, in the bradykinin-nociception test
in mice was mediated through protein kinase C activation.
This article has been cited by other articles:
![]() |
K. A. Berg, A. M. Patwardhan, T. A. Sanchez, Y. M. Silva, K. M. Hargreaves, and W. P. Clarke Rapid Modulation of {micro}-Opioid Receptor Signaling in Primary Sensory Neurons J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 839 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Johnson, S. Oldfield, E. Braksator, A. Gonzalez-Cuello, D. Couch, K. J. Hall, S. J. Mundell, C. P. Bailey, E. Kelly, and G. Henderson Agonist-Selective Mechanisms of {micro}-Opioid Receptor Desensitization in Human Embryonic Kidney 293 Cells Mol. Pharmacol., August 1, 2006; 70(2): 676 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Bailey, E. Kelly, and G. Henderson Protein Kinase C Activation Enhances Morphine-Induced Rapid Desensitization of {micro}-Opioid Receptors in Mature Rat Locus Ceruleus Neurons Mol. Pharmacol., December 1, 2004; 66(6): 1592 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Guang, H. Wang, T. Su, I. B. Weinstein, and J. B. Wang Role of mPKCI, a Novel {micro}-Opioid Receptor Interactive Protein, in Receptor Desensitization, Phosphorylation, and Morphine-Induced Analgesia Mol. Pharmacol., November 1, 2004; 66(5): 1285 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Rashid, M. Inoue, M. Matsumoto, and H. Ueda Switching of Bradykinin-Mediated Nociception Following Partial Sciatic Nerve Injury in Mice J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1158 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inoue, T. Kawashima, R. G. Allen, and H. Ueda Nocistatin and Prepro-Nociceptin/Orphanin FQ 160-187 Cause Nociception through Activation of Gi/o in Capsaicin-Sensitive and of Gs in Capsaicin-Insensitive Nociceptors, Respectively J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 141 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Bohn, R. J. Lefkowitz, and M. G. Caron Differential Mechanisms of Morphine Antinociceptive Tolerance Revealed in beta Arrestin-2 Knock-Out Mice J. Neurosci., December 1, 2002; 22(23): 10494 - 10500. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Mandyam, D. R. Thakker, J. L. Christensen, and K. M. Standifer Orphanin FQ/Nociceptin-Mediated Desensitization of Opioid Receptor-Like 1 Receptor and {micro} Opioid Receptors Involves Protein Kinase C: A Molecular Mechanism for Heterologous Cross-Talk J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 502 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ueda, M. Inoue, A. Yoshida, K. Mizuno, H. Yamamoto, J. Maruo, K. Matsuno, and S. Mita Metabotropic Neurosteroid/sigma -Receptor Involved in Stimulation of Nociceptor Endings of Mice J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 703 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ueda, M. Inoue, and T. Matsumoto Protein Kinase C-Mediated Inhibition of {micro}-Opioid Receptor Internalization and Its Involvement in the Development of Acute Tolerance to Peripheral {micro}-Agonist Analgesia J. Neurosci., May 1, 2001; 21(9): 2967 - 2973. [Abstract] [Full Text] [PDF] |
||||